Work

Corrigendum: Combining the SMAC mimetic LCL161 with Gemcitabine plus Cisplatin therapy inhibits and prevents the emergence of multidrug resistance in cholangiocarcinoma

Year: 2023

Type: erratum

Abstract: [This corrects the article DOI: 10.3389/fonc.2022.1021632.].

Source: Frontiers in Oncology

DOI: 10.3389/fonc.2022.1124912

Authors: Sunisa Prasopporn, Orawan Suppramote, Ben Ponvilawan, Chanette Jamyuang, Jantappapa Chanthercrob, Amphun Chaiboonchoe, Pimkanya More-Krong, Kamonchanok Kongsri, Monthira Suntiparpluacha, Rawisak Chanwat, Krittiya Korphaisarn, Seiji Okada, Somponnat Sampattavanich, Siwanon Jirawatnotai

Institutions: Siriraj Hospital, Mahidol University, Chulabhorn Royal Academy, National Cancer Institute of Thailand, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto University

Language: English

Topic: Cholangiocarcinoma and Gallbladder Cancer Studies

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,295

Funders: National Science and Technology Development Agency, Japan Science and Technology Agency

OpenAlex ID: W4313612704

Cites:

Cited by: 2

Related to: 10